Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Value of Eye Metrics as Biomarkers for Neurocognitive Function in Paediatric Brain Tumour Survivors?
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Clinical and translational research in pediatric oncology.ORCID iD: 0000-0002-1388-1826
Uppsala University, Disciplinary Domain of Humanities and Social Sciences, Faculty of Social Sciences, Department of Psychology.ORCID iD: 0000-0002-4310-3224
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer Immunotherapy.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer precision medicine.
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Abstract [en]

Background: Long-term follow up of neurocognitive late effects in paediatric brain tumour survivors (PBTS) is essential, particularly after radiotherapy (RT). Processing speed impairments are among the most prevalent late effects, yet their relation to underlying oculomotor control and visual attention remains unclear. Eye movement metrics reflect the integrity of neural systems supporting attention, visual processing, and executive control, and may serve as sensitive potential biomarkers of neurocognitive impairment, complementing neuropsychological assessment. To explore this, we employed a pro–antisaccade task to examine fundamental oculomotor and executive control processes. The primary aim was to assess whether PBTS showed impaired pro-antisaccade performance compared with age-matched controls. Within the PBTS group, we also examined associations between saccadic latency, processing speed, and RT doses to brain structures important for visual and neurocognitive networks.

Methods: This long-term case-control study included 21 PBTS treated with proton and/or photon RT 8-20 years earlier and 50 age-matched controls. PBTS were aged 15-34 years (mean 23; 12 males and 9 females), and controls were aged 18-34 years (mean 26; 25 males, 24 females, and one non-binary participant). Eye movements were measured with an eye-tracker, and participants were instructed to look either towards an upcoming target (pro-saccades) or away from it (anti-saccades). Between-group differences were analysed using independent t-tests (Cohen´s d effect sizes) and modified t-tests for single samples to identify individual impairments. Within the PBTS group, we further explored associations between saccadic latency, processing speed, and mean RT doses to established and potential new organs at risk.

Results: PBTS demonstrated significantly longer pro- and antisaccade latencies than controls, with effect sizes ranging from small to large and the greatest impairments in those who received whole-brain RT. Modified t-tests revealed that nearly half of the PBTS performed in the impaired range on the anti-saccade task relative to the control reference group. Within the PBTS group, longer saccadic latency correlated with slower processing speed and with higher mean RT doses to the optic nerves and pons.

Conclusion: PBTS demonstrated long-term impairments in pro- and antisaccade performance many years after RT, with longer saccadic latencies linked to higher RT doses and slower processing speed. These patterns suggest lasting disruptions in visual attention, oculomotor, and executive networks. Eye-tracking offers a sensitive measure for detecting subtle neurocognitive late effects that can complement neuropsychological assessment and may help inform targeted rehabilitation strategies. 

Keywords [en]
CNS-tumour, childhood, radiation, risk organ, eye-tracker, saccadic reaction time
National Category
Pediatrics Cancer and Oncology
Research subject
Medical Science
Identifiers
URN: urn:nbn:se:uu:diva-577662OAI: oai:DiVA.org:uu-577662DiVA, id: diva2:2032634
Funder
Swedish Childhood Cancer Foundation, PR2018-0042, TJ018-0046
Note

Gustaf Ljungman and Johan Kundin Kleberg share senior authorship.

Available from: 2026-01-27 Created: 2026-01-27 Last updated: 2026-01-27
In thesis
1. Pediatric Brain Tumor Survivors after Radiotherapy: Long-Term Neurocognitive Outcomes, Oculomotor Function, and Arousal
Open this publication in new window or tab >>Pediatric Brain Tumor Survivors after Radiotherapy: Long-Term Neurocognitive Outcomes, Oculomotor Function, and Arousal
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Pediatric brain tumor survivors (PBTS) are at increased risk of long-term neurocognitive late effects, particularly following radiotherapy (RT), with processing speed being one of the domains most commonly impaired. The developing brain is particularly vulnerable to RT, and long-term neuropsychological follow-up is therefore recommended. Most studies addressing this topic have primarily focused on prescribed dose, planning target volume (PTV), and whole-brain radiotherapy (WBRT) dose, whereas the association between mean radiation dose to organs at risk (OAR) and neurocognitive outcomes remains insufficiently explored. Although neurocognitive functioning is routinely assessed through standardized neuropsychological testing, eye-tracking measures—including eye movements and pupillometry—may serve as sensitive complementary indicators of attention, processing speed, arousal, and executive functioning.

This thesis investigated neurocognitive outcomes in relation to different RT dose measures, including PTV dose and mean RT dose to established and potential new OAR, using both neuropsychological assessment and eye-tracking metrics. Additional clinical risk factors were also explored. Both retrospective and prospective studies of PBTS treated with RT between 2003-2015 were included. Neurocognitive function was assessed before, after, and 8–20 years post-RT. Long-term outcomes were related to RT dose parameters, and eye-tracking and fatigue were compared with age-matched controls.

Neurocognitive impairments were present prior to RT and became more prevalent with increasing time after treatment. Higher PTV dose was associated with lower working memory performance. Higher mean RT doses to several established and potential new OAR were associated with lower intelligence quotient and processing speed, as well as impaired oculomotor performance, altered pupil responses, and higher fatigue. WBRT and larger tumor size were also linked to poorer outcomes. 

In conclusion, the findings from this thesis show that PBTS are at elevated risk of long-term neurocognitive, oculomotor, and arousal-related difficulties following RT. Mean RT dose to OAR provides valuable information on radiation-related impairment beyond PTV dose. These findings underscore the need of structured neuropsychological follow-up. They further demonstrate the value of mean RT dose metrics an eye-tracking measures in evaluating radiation-related neurocognitive outcomes and guiding targeted treatment and rehabilitation strategies.  

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2026. p. 83
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2229
Keywords
Pediatric brain tumor, radiotherapy, organs at risk, mean dose, neurocognition, processing speed, fatigue, eye-tracking, pupillometry
National Category
Pediatrics Cancer and Oncology
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-577656 (URN)978-91-513-2726-6 (ISBN)
Public defence
2026-03-13, Universitetshuset, sal IV, Biskopsgatan 3, Uppsala, 09:15 (Swedish)
Opponent
Supervisors
Funder
Swedish Childhood Cancer Foundation, PR2013-0062,PR2018-0042, TJ2018-0046
Available from: 2026-02-19 Created: 2026-01-27 Last updated: 2026-02-20

Open Access in DiVA

No full text in DiVA

Authority records

Söderström, HelenaBrocki, KarinMartinsson, UllaIsacsson, UlfLjungman, GustafLundin Kleberg, Johan

Search in DiVA

By author/editor
Söderström, HelenaBrocki, KarinMartinsson, UllaIsacsson, UlfLjungman, GustafLundin Kleberg, Johan
By organisation
Clinical and translational research in pediatric oncologyDepartment of PsychologyCancer ImmunotherapyCancer precision medicine
PediatricsCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 17 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf